Status:
UNKNOWN
Treatment of Chronic Fatigue Syndrome (CFS) With Iodinated Activated Charcoal (IodoCarb®)
Lead Sponsor:
PharmaLundensis AB
Conditions:
Chronic Fatigue Syndrome
Eligibility:
All Genders
35-60 years
Phase:
PHASE1
PHASE2
Brief Summary
Chronic fatigue syndrome (CFS) is a devastating and complex disorder. People with CFS experience overwhelming fatigue and a host of other symptoms that are not improved by bed rest. Interestingly, man...
Detailed Description
Chronic fatigue syndrome (CFS, which is also sometimes called ME, Myalgic Encephalomyelitis) is a devastating and complex disorder. People with CFS experience overwhelming fatigue and a host of other ...
Eligibility Criteria
Inclusion
- Chronic fatigue syndrome
- 35-60 years old
- Male
- Female (not pregnant or breastfeeding, using adequate highly effective contraception consistently and correctly or \>1 year post-menopausal or surgically sterile).
Exclusion
- Iodine allergy
- abnormal thyroid function or other thyroid disease such as goiter
- severely reduced kidney function (Cystatin C \> 1.5 mg/L)
- alcohol/drug abuse
- severe depression
- severe fibromyalgia
- severe cardio-vascular disease
- other severe disease, according to the clinical investigator
- participation in another ongoing clinical trial
- participation in drug trial the preceding 3 months
Key Trial Info
Start Date :
February 1 2013
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 1 2013
Estimated Enrollment :
40 Patients enrolled
Trial Details
Trial ID
NCT01793415
Start Date
February 1 2013
End Date
December 1 2013
Last Update
February 15 2013
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Probare i Lund AB
Lund, Sweden, SE-222 22